Primary pericardial mesothelioma: a case report of a patient treated with an immune checkpoint inhibitor as the second-line treatment

Authors

  • Otso Arponen Department of Radiology, Päijät-Häme Central Hospital, Lahti, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
  • Virpi Salo Department of Radiology, Päijät-Häme Central Hospital, Lahti, Finland
  • Annika Lönnberg Department of Cardiology, Päijät-Häme Central Hospital, Lahti, Finland
  • Leila Vaalavirta Department of Oncology, Helsinki University Hospital, Helsinki, Finland
  • Hannu Koivu Department of Nuclear Medicine, Päijät-Häme Central Hospital, Lahti, Finland
  • Paul Nyandoto Department of Oncology, Helsinki University Hospital, Helsinki, Finland; Department of Oncology, Päijät-Häme Central Hospital, Lahti, Finland

DOI:

https://doi.org/10.1080/0284186X.2021.1887515

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2021-05-04

How to Cite

Arponen, O., Salo, V., Lönnberg, A., Vaalavirta, L., Koivu, H., & Nyandoto, P. (2021). Primary pericardial mesothelioma: a case report of a patient treated with an immune checkpoint inhibitor as the second-line treatment. Acta Oncologica, 60(5), 687–691. https://doi.org/10.1080/0284186X.2021.1887515

Issue

Vol. 60 No. 5 (2021): Acta Oncologica

Section

Articles